Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 26 Oct 2012 |
| Interim report for the first 9 months of 2012 | 25 Oct 2012 |
| Share buyback program - Novozymes A/S B shares | 19 Oct 2012 |
| Share buyback program - Novozymes A/S B shares | 12 Oct 2012 |
| Share buyback program - Novozymes A/S B shares | 5 Oct 2012 |